Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Toopi Organics

Active#23 worldwide · Biological inputs

Collects human urine and turns it into microbial biostimulants and biofertilisers, using lactic bacteria fermentation to supply farmers with a partial replacement for mineral fertilisers.

HQFrance
Last roundSeries A · Sep 2023

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Biological inputs · worldwideTop 32#23Edition 0 · Oct 202612 Feb 2027
Rank historyOct 2026 · #23 Biological inputsFirst edition: no movements yet.

Estimated valuation

AI · Biological inputs ranking (worldwide)
≈ USD 61MUSD 41–91M · Tens of M$
Anchor
Last known equity round: Series A · USD 11.8M · Sep 2023

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

DateRoundAmountTypeInvestors
Sep 2023Series AUSD 11.8MEquityVisVires New Protein, Edaphon, MAIF Impact, BNP Paribas Développement

EUR 11M equity at ~1.07 USD/EUR (Sept 2023); total EUR 16M incl. ~EUR 5M non-dilutive excluded.

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Toopi Organics as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $61MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in biological inputs

Full biological inputs ranking →

Investors in Toopi Organics: VisVires New Protein · Edaphon · MAIF Impact · BNP Paribas Développement

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.